Two new trustees appointed by The Royal Marsden Cancer Charity
We are pleased to welcome Andrew Fisher OBE and Roger Gray who have been appointed as new Trustees and bring with them a wealth of experience and expertise.
Andrew Fisher OBE and Roger Gray both bring extensive experience to their new roles, which they took up in December 2022. Roger’s role will also include chairing the Charity’s Investment Committee.
Antonia Dalmahoy, Managing Director of The Royal Marsden Cancer Charity, said:
“We are so pleased to welcome Andrew Fisher OBE and Roger Gray to The Royal Marsden Cancer Charity. They bring with them a wealth of experience and expertise which will be immensely valuable and I look forward to working alongside them to help The Royal Marsden continue to save and improve the lives of people affected by cancer.”
Andrew Fisher OBE
“It is a privilege to join The Royal Marsden Cancer Charity as a Trustee as it continues its incredible work." says Andrew. "I look forward to working closely with my fellow Trustees and the Charity’s team to help The Royal Marsden continue to deliver excellence across cancer research, diagnosis, treatment and care.”
Andrew is Chair of Rightmove plc and Chair of Epidemic Sound as well as a Non-Executive Director of Marks and Spencer Group plc. He was appointed CEO of Shazam in March 2005 and became Executive Chairman in 2013. The company was acquired by Apple in 2018.
He was a member of The Royal Marsden Cancer Charity’s Oak Cancer Centre Appeal Board and has been a Non-Executive Director of MoneySuperMarket Group plc and Merlin Entertainments plc, as well as a member of the Council of Loughborough University. In 2016, Andrew was awarded an OBE in recognition for his services to the digital economy.
Roger Gray
“The Royal Marsden Cancer Charity plays an important role in driving forward the world-leading cancer care and research that The Royal Marsden is known for." says Roger. "I am really delighted to be working with the Charity to help continue this work, ensuring that the hospital achieves the very best outcomes for cancer patients.”
Roger studied Philosophy, Politics and Economics at Oxford University and then Economics at Harvard University before embarking on a career in investment management spanning four decades.
He began in the asset management business at Rothschild Asset Management where he rose to Chief Investment Officer (CIO), before moving to UBS Asset Management (Switzerland) as CEO and CIO and then Global Head of Asset Allocation/Currency. His later career was spent as CIO for the UK’s two largest pension funds, at Hermes for the BT Pension Scheme and then for 10 years at USS Investment Management Ltd on behalf of the Universities Superannuation Scheme.
His portfolio of non-executive activities includes the Countess of Munster Musical Trust, the Winchester College Investment Committee and the Triago Advisory Board.
About our trustees
We are a registered charity, governed by an independent board of trustees and a director.
Our trustees are jointly responsible for running the Charity and for making sure that all the funding we receive goes towards achieving the best outcomes for cancer patients at The Royal Marsden and across the UK by continuously driving for excellence in all areas of cancer research, diagnosis, treatment and care.
Discover more news and stories on our blog.